Although ENaC inhibitors such as amiloride and triamterene are known to reduce BP [68], these are not used as first-line antihypertensive agents primarily because of their low receptor selectivity.
Blockers of RAAS such as ACEIs, ARBs, direct renin inhibitors (DRIs), and MRBs are the most frequently used agents.